HanidAudishDO

Clinical Trials

• A Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects Start of enrollment: 2015 Sep 09

  Completed

  Phase 2

• Single-Dose Administration Trial of TLC599 in Osteoarthritis of the Knee Start of enrollment: 2015 Jun 01

  Completed

  Phase 1, Phase 2

• A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2017 May 24

  Completed

  Phase 2

• A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men Start of enrollment: 2018 May 03

  Completed

  Phase 4

• Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity Start of enrollment: 2018 Oct 24

  Completed

  Phase 3

• A Study to Assess Efficacy and Safety of GLPG1972/S201086 in Participants With Knee Osteoarthritis Start of enrollment: 2018 Aug 14

  Completed

  Phase 2

• An Open-label, 8-week Safety, Efficacy, and Assessment of Cooling Methods for Administration of CNTX-4975-05 for Knee OA Start of enrollment: 2018 Sep 18

  Completed

  Phase 3

• Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Start of enrollment: 2018 Sep 26

  Terminated

  Phase 3

• Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine Start of enrollment: 2018 Oct 08

  Completed

  Phase 3

• Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s) Start of enrollment: 2018 Nov 09

  Terminated

  Phase 3

• Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Alone or in Combination With Sulfonylurea Start of enrollment: 2019 Aug 01

  Terminated

  Phase 3

• Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity. Start of enrollment: 2019 Mar 01

  Completed

  Phase 2

• A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes Start of enrollment: 2019 Apr 01

  Completed

  Phase 3

• A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine Start of enrollment: 2019 Jun 24

  Completed

  Phase 3

• A Double-blind Study to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus Start of enrollment: 2019 Jul 18

  Completed

  Phase 2

• Multimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT) Start of enrollment: 2019 Jul 06

  Completed

  Phase 3

• Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049) Start of enrollment: 2020 Feb 27

  Active, not recruiting

  Phase 3

• Join now to see all